Actionable news
All posts from Actionable news
Actionable news in ALXN: Alexion Pharmaceuticals, Inc.,

ALEXION PHARMACEUTICALS INC (ALXN) Earnings Report: Q3 2015 Conference Call Transcript

Incorporated third-quarter results conference call.


Today's call is being recorded. For opening remarks and introductions, IÕd like to turn the call over to Ms. Elena Ridloff, Executive Director of Investor Relations. Please go ahead Ma'am. Elena Ridloff (Executive Director of IR): Thank you. Good morning. Thank you for joining us on today's call to discuss Alexion's performance for the third quarter of and updated plans for the full year. Today's call will be led by David Hallal, our CEO. David will start the call with an overview of our global performance and be joined by Vikas Sinha, our Chief FInancial Officer, and Carsten Thiel, our Chief Commercial Officer, as well as Martin Mackay, our Global Head of R&D. ALso with us today are Saqib Islam, our Chief Strategy and Portfolio Officer, and Julia O'Neill, our Global Head of Operations. You can access the webcast slides that will be presented on this call by going to the Events section of our investor relations page on our website. Before we begin I will refer you to slide . We will make forward-looking statements, all of which involve certain assumptions, risks, and uncertainties that are beyond our control and could cause our actual results to differ materially from these statements. A description of these risks can be found at our most recent Q and K filings with the SEC, and our subsequent SEC filings...